Fierce Pharma Biopharma News Insights Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance
News - Pharmaceutical Commerce News | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market
News | PharmExec In today’s Pharmaceutical Executive Daily, leadership turnover continues across key federal health agencies under the Trump administration, Shionogi enters a $2 billion agreement to acquire rights to Radicava, and the FTC examines antitrust concerns tied to CVS Health’s integrated healthcare model
Healthcare Pharmaceutical Healthcare Pharmaceutical Biotech Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place
Pharma, Biotech and Generics Industry News | The Pharmaletter Pharmaceutical Lilly to acquire Centessa to advance treatments for sleep-wake disorders Shares of US clinical-stage drug developer Centessa Pharmaceuticals leapt 44% to $39 72 on the news that it has reached a definitive agreement for US pharma major Eli Lilly to acquire the company 1 April 2026 Pharmaceutical Merck bids $6 7 billion for Terns Pharmaceuticals US pharma giant Merck Co and
Pharmaceuticals sector - Financial Times Comprehensive coverage of the pharmaceuticals industry The latest news and developments from the world's leading drug companies, including Pfizer, Johnson Johnson, AstraZeneca and more
News - PharmaTimes Axplora has announced plans to build a 4,500sqm R D and laboratory hub at its Farmabios site in Gropello Cairoli in Italy DNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access to its SYNTAX platform